Results 191 to 200 of about 797,426 (292)

Evaluating Digital Health Solutions in Diabetes and the Role of Patient-Reported Outcomes: Targeted Literature Review. [PDF]

JMIR Diabetes
Cerletti P, Joubert M, Oliver N, Ghafur S, Varriale P, Wilczynski O, Gyldmark M.   +6 more
europepmc   +1 more source

Antimicrobial stewardship programs in acute-care hospitals: a multicenter assessment of structure, process, and outcome indicators in Italy and Spain

Giuseppina Lo Moro, Noemi Marengo, Alessandro Mara, José Ramón Paño Pardo, Sergi Hernández, Ester Fusté, Miquel Pujol, Carla Maria Zotti, Enrique Limón Cáceres, Costanza Vicentini   +9 more
openalex   +1 more source

Transplant center assessment of the inequity in the kidney transplant process and outcomes for the Indigenous American patients

, 2018
Mira T. Keddis, Amit Sharma, Muneeb Ilyas, Nan Zhang, Hasan Khamash, Scott J. Leischow, Raymond L. Heilman   +6 more
openalex   +2 more sources

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

Human health risk assessment for microbial pesticides in the EU: challenges and perspectives. [PDF]

Environ Health
Barrero-Canosa J, Ebeling J, Kenny EF, Marx-Stoelting P, Paege N, Feustel S, Leme DM.   +6 more
europepmc   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Revealing the Patient Perspective: Evolution of Patient-Reported Outcome Measures in Botulinum Toxin Studies in Aesthetic Medicine. [PDF]

J Cosmet Dermatol
Dayan S, Rivkin AZ, Ogilvie P, Carruthers JDA, Wu Y, Lee E, Patel V, Musumeci M.   +7 more
europepmc   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Assessment-Focused Pedagogical Methods for Improving Student Learning Process and Academic Outcomes in Accounting Disciplines

Mădălina Dumitru, Voicu D. Dragomir
openalex   +1 more source

Beyond cytotoxic T cells: reprogrammed regulatory T cells help facilitate response to dual checkpoint blockade

Molecular Oncology, EarlyView.
Rolig, Peng, and colleagues have shed new light on how dual blockade of PD1 and LAG3 enhances antitumor immunity. They found that response to immunotherapy with anti‐PD1 + anti‐LAG3 was associated with reprogramming of canonically suppressive CD4+ regulatory T cells to an inflammatory state.
Tullia C. Bruno, Anthony R. Cillo
wiley   +1 more source